241 related articles for article (PubMed ID: 29942398)
1. Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals.
Choi JY
Nucl Med Mol Imaging; 2018 Jun; 52(3):200-207. PubMed ID: 29942398
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters.
Wieder HA; Lassmann M; Allen-Auerbach MS; Czernin J; Herrmann K
World J Radiol; 2014 Jul; 6(7):480-5. PubMed ID: 25071888
[TBL] [Abstract][Full Text] [Related]
3. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
Pandit-Taskar N; Larson SM; Carrasquillo JA
J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
[TBL] [Abstract][Full Text] [Related]
4. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
[TBL] [Abstract][Full Text] [Related]
5. Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain.
Manafi-Farid R; Masoumi F; Divband G; Saidi B; Ataeinia B; Hertel F; Schweighofer-Zwink G; Morgenroth A; Beheshti M
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32806765
[TBL] [Abstract][Full Text] [Related]
6. Radium-223 dichloride in clinical practice: a review.
Florimonte L; Dellavedova L; Maffioli LS
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689
[TBL] [Abstract][Full Text] [Related]
7. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.
Henriksen G; Fisher DR; Roeske JC; Bruland ØS; Larsen RH
J Nucl Med; 2003 Feb; 44(2):252-9. PubMed ID: 12571218
[TBL] [Abstract][Full Text] [Related]
8. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA
Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915
[TBL] [Abstract][Full Text] [Related]
9. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
Paes FM; Serafini AN
Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678
[TBL] [Abstract][Full Text] [Related]
10. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar N; Batraki M; Divgi CR
J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
[TBL] [Abstract][Full Text] [Related]
11. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
Badawi JK
Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
[TBL] [Abstract][Full Text] [Related]
12. An assessment of bone-seeking radionuclides for palliation of metastatic bone pain in a vertebral model.
Sadremomtaz A; Masoumi M
Ann Nucl Med; 2019 Apr; 33(4):252-264. PubMed ID: 30659480
[TBL] [Abstract][Full Text] [Related]
13. Targeted radiotherapy of bone malignancies.
Jansen DR; Krijger GC; Kolar ZI; Zonnenberg BA; Zeevaart JR
Curr Drug Discov Technol; 2010 Dec; 7(4):233-46. PubMed ID: 21034411
[TBL] [Abstract][Full Text] [Related]
14. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions.
Dash A; Das T; Knapp FFR
Curr Med Chem; 2020; 27(19):3187-3249. PubMed ID: 30714520
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the future.
Ferreira S; Dormehl I; Botelho MF
Cancer Biother Radiopharm; 2012 Nov; 27(9):535-51. PubMed ID: 23075374
[TBL] [Abstract][Full Text] [Related]
16. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
[TBL] [Abstract][Full Text] [Related]
17. Isotope Therapy for Castrate-Resistant Prostate Cancer: Unique Sequencing and Combinations.
Sartor O
Cancer J; 2016; 22(5):342-346. PubMed ID: 27749328
[TBL] [Abstract][Full Text] [Related]
18. Integrating bone targeting radiopharmaceuticals into the management of patients with castrate-resistant prostate cancer with symptomatic bone metastases.
Blacksburg SR; Witten MR; Haas JA
Curr Treat Options Oncol; 2015 Mar; 16(3):325. PubMed ID: 25777571
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
